230 related articles for article (PubMed ID: 29025581)
1. Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia.
Wasilewska EM; Panasiuk B; Gniot M; Sawicka A; Kozłowska K; Lewandowski K; Kłoczko J; Midro AT
Cancer Genet; 2017 Oct; 216-217():1-9. PubMed ID: 29025581
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of clonal chromosomal abnormalities in Philadelphia negative cells in CML patients after treated with tyrosine kinase inhibitors.
Ni H; Sun X; Xu Y; Lyle D; Petersen P; Zhao X; Drum H; You B; Liu D; Liu C; Jiang JG
Cancer Genet; 2019 Oct; 238():44-49. PubMed ID: 31425925
[TBL] [Abstract][Full Text] [Related]
3. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
Terre C; Eclache V; Rousselot P; Imbert M; Charrin C; Gervais C; Mozziconacci MJ; Maarek O; Mossafa H; Auger N; Dastugue N; Talmant P; Van den Akker J; Leonard C; N'Guyen Khac F; Mugneret F; Viguié F; Lafage-Pochitaloff M; Bastie JN; Roux GL; Nicolini F; Maloisel F; Vey N; Laurent G; Recher C; Vigier M; Yacouben Y; Giraudier S; Vernant JP; Salles B; Roussi J; Castaigne S; Leymarie V; Flandrin G; Lessard M;
Leukemia; 2004 Aug; 18(8):1340-6. PubMed ID: 15190256
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
O'Dwyer ME; Gatter KM; Loriaux M; Druker BJ; Olson SB; Magenis RE; Lawce H; Mauro MJ; Maziarz RT; Braziel RM
Leukemia; 2003 Mar; 17(3):481-7. PubMed ID: 12646934
[TBL] [Abstract][Full Text] [Related]
5. [Philadelphia chromosome-negative myeloid neoplasms in patients with Philadelphia chromosome-positive chronic myeloid leukemia during tyrosine kinase inhibtor-therapy].
Yuan T; Wang XY; Lai YY; Qin YZ; Shi HX; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):547-553. PubMed ID: 32397016
[No Abstract] [Full Text] [Related]
6. [The influence of additive clonal chromosome abnormalities in Ph negative cells on the efficacy of chronic myeloid leukemia].
Zhao HF; Zhang Y; Zu YL; Li Z; Zhou J; Yu FK; Hu JY; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):803-807. PubMed ID: 31665854
[No Abstract] [Full Text] [Related]
7. The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.
Crisan AM; Coriu D; Arion C; Colita A; Jardan C
J Med Life; 2015; 8(4):502-8. PubMed ID: 26664479
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T
Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis of clonal chromosomal abnormalities in Philadelphia negative metaphases cells in chronic myeloid leukemia with tyrosine kinase inhibitor therapy].
Zhao HF; Zhang Y; Hu JY; Li Z; Zhou J; Yu FK; Zu YL; Zhou H; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):209-214. PubMed ID: 30929388
[No Abstract] [Full Text] [Related]
10. [Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosine kinases].
Turkina AG; Domracheva EV; Vorontsova AV; Aseeva EA; Vinogradova OIu; Stakhina OV; Gusarova GA; Diagileva OA; Semenova EA; Vakhrusheva MV; Kolosheĭnova TI; Abakumov EM; Chelysheva EIu; Goriacheva SR; Ivanova TV; Zakharova ES; Kolosova LIu; Zakharova AV; Naumova IN; Diachenko LV; Kulikov SM; Kovaleva LG; Khoroshko ND
Ter Arkh; 2009; 81(7):29-36. PubMed ID: 19708570
[TBL] [Abstract][Full Text] [Related]
11. Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia.
Ariyama T; Inazawa J; Uemura Y; Kakazu N; Maekawa T; Urase F; Irimajiri K; Horiuchi A; Nakamura Y; Abe T
Cancer Genet Cytogenet; 1995 May; 81(1):20-3. PubMed ID: 7773954
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal relationship between a Ph-negative clone with trisomy 8 associated with severe myelodysplasia and a Ph-positive clone following imatinib treatment in a patient with accelerated-phase chronic myelogenous leukemia (CML).
Patchenko P; Klepfish A; Trakhtenbrot L; Rothman R; Rachmilewitz EA
Am J Hematol; 2004 Dec; 77(4):420. PubMed ID: 15558793
[No Abstract] [Full Text] [Related]
13. Persistent clonal chromosomal abnormalities in a chronic myeloid leukemia patient.
Muraoka M; Washio K; Kanamitu K; Kanazawa Y; Ishida T; Miyamura T; Chayama K; Nishiuchi R; Oda M; Shimada A
Pediatr Int; 2016 Jan; 58(1):53-6. PubMed ID: 26542480
[TBL] [Abstract][Full Text] [Related]
14. Potential role for second‑generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.
Ishikawa M; Iriyama N; Tokuhira M; Takaku T; Sato E; Sugimoto KJ; Nakazato T; Fujita H; Kimura Y; Fujioka I; Komatsu N; Asou N; Kizaki M; Hatta Y; Kawaguchi T
Oncol Rep; 2019 Dec; 42(6):2836-2843. PubMed ID: 31578586
[TBL] [Abstract][Full Text] [Related]
15. Rare monosomy 7 and deletion 7p at diagnosis of chronic myeloid leukemia in accelerated phase.
Alswied A; Rehman A; Lai LW; Duran J; Sardar M; Proytcheva MA
Cancer Genet; 2021 Apr; 252-253():111-114. PubMed ID: 33497941
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia.
Groves MJ; Sales M; Baker L; Griffiths M; Pratt N; Tauro S
Cancer Genet; 2011 Jan; 204(1):39-44. PubMed ID: 21356190
[TBL] [Abstract][Full Text] [Related]
17. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.
Deininger MW; Cortes J; Paquette R; Park B; Hochhaus A; Baccarani M; Stone R; Fischer T; Kantarjian H; Niederwieser D; Gambacorti-Passerini C; So C; Gathmann I; Goldman JM; Smith D; Druker BJ; Guilhot F
Cancer; 2007 Oct; 110(7):1509-19. PubMed ID: 17702093
[TBL] [Abstract][Full Text] [Related]
18. Case Report of acute myeloid leukemia with "WT1, ATRX, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19" developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy.
Zhu H; Yang B; Liu J; Wu W; Ling Y
Medicine (Baltimore); 2020 Jan; 99(3):e18888. PubMed ID: 32011516
[TBL] [Abstract][Full Text] [Related]
19. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
20. The cytogenetic scenario of chronic myeloid leukemia.
Mitelman F
Leuk Lymphoma; 1993; 11 Suppl 1():11-5. PubMed ID: 8251885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
